Skip to content

Sight Sciences, Inc. SGHT Change in Inventories

Change in Inventories at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$431M+195%
Glaukos logo
GlaukosGKOS
-$832K-150%
AbbVie logo
AbbVieABBV
$184M+18.7%
Bausch + Lomb logo
Bausch + LombBLCO
$22M+83.3%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$196K+133%
Boston Scientific logo
Boston ScientificBSX
$177M+62.4%

Other financials

Income statement

See full
Revenue$19.7M+12.5%
Gross profit$17.0M+12.5%
Operating income-$12.4M+10.4%
Net income-$13.0M+8.3%
EPS (diluted)-$0.24+14.3%

Balance sheet

See full
Cash & equivalents$85.0M-21.9%
Total debt$40.9M+1.1%
Total equity$53.9M-30.6%
Total assets$109.7M-15.4%

Cash flow

See full
Operating cash flow-$7.0M+39.4%
CapEx$60.0K
Free cash flow-$7.1M+38.9%

Valuation

See full
Market cap$294.9M+35.0%
Enterprise value$250.83M+59.0%
P/S3.7×+0.8×

Profitability

See full
Gross margin86.2%+0.5pp
Operating margin-44.8%-10.2pp
Net margin-46.8%-9.6pp
FCF margin-31.9%+0.2pp

Returns & leverage

See full
Return on equity-56.6%+4.3pp
Debt / equity0.8×+0.2×
Current ratio5.9×-4.6×

Where this comes from

Reported directly by Sight Sciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.

The official record: Sight Sciences, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sight Sciences, Inc.'s change in inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sight Sciences, Inc.'s change in inventories?
Sight Sciences, Inc. (SGHT) reported change in inventories of -$788K in Q1 2026.
How has Sight Sciences, Inc.'s change in inventories changed year-over-year?
Sight Sciences, Inc.'s change in inventories decreased by 45.7% year-over-year, from -$541K to -$788K.
What does change in inventories mean?
Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.